Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Greg can only issue the 8K when it is ready. Why does everyone blame Greg, like he has control....he's the PR guy, he is not who determines when the 8K gets posted. Stop blaming poor Greg. The PR guy reports to senior management, you know his Papa!!
So your comparing a fortune 500 company with an OTC.... enough said
So your saying your going to miss out on the really big move, but you cashed out for chump change...
Sad when someone is ridiculing a company because mattresses were not on the floor at the showman.....like this deal really hinges on mattresses!!!
re posting old news eveyone know the merge will provide money as well as the new agreements with investment houses....come on can you come up with something new at least!!!!
Now he's speaking latin....too funny!!!
ok I confess it was I!!! lol
Bro so what. What is the point and the end result....
SEC Rotman's is private;ly held and if it was a big deal why isn't the SEC visiting Greg. Your are way off on this point. Good luck with it
Waiting with bated breath!!! LOL
If I recall the person he supposedly said that to shared it with everyone else so it was made available to everyone
I never said anything about rule 144. That piece is added for confusion and nothing more. As you say he cannot sell/buy on any inside information as he is to close to what's going on or as was just stated insider :"by Nature", so goes to surmise that none of the shares that he or Jamie have are being sold since they are in fact privy to what's going on with VYST and Rotman's
Okay as an insider he cannot sell shares neither can jamie so now you are agreeing that neither one of them have sold shares since by law they prohibited dur to the information they are privy to!!!
I like that phrase "by nature" you should have a conversation with TENKAY who has made it his mission to indicate that neither Greg or Jamie are insiders!!!!! Well now I must say I agree with with the by nature,. so let FINRA worry about his statement we can now rest assurred that as a "by Nature" insider he nor jamie are selling any shares. Thank you for clarifying!!!!
Choose one, TENKAY keeps saying Greg is not an insider, well Greg released the info, so which is it is he an isider or not!!!!
Rotman's is a private company not traded so whatever information they want to release and to whom is their business
It's not a strategy it takes time to finalize the deal. If your impatient move on!!!
That would be the case if other investors didnt get spooked, but even with the controlled exchange and by all rights miniscule changes in SP investors will get spooked and sell
you have said countless times you dont know who's making those trades or why. Now you want to insinuate something different!!!
The reduction in the price of the stock are the retial investors who get spooked and wind up selling instead of being patient!!!
What is the meaning of these trades, why do you continue to post??
Privately held family business you have no idea what the brothers have given to their progeny!!!
The original question was Tenkay posting that they are not insiders, a very black and white response. What I am saying is that Greg and Jamie are intimately tied to Rotman's through family ownership. Since it is a private company, we do not know if the brothers have provided them with actual % ownership, that remains to be seen. In addtion Greg and Jamie are privy to day to day transactions at Rotman's which would provide information relative to the VYST, afterall Steve is President/CEO at VYST and 42% owner of Rotman's. So yes in my eyes Greg and Jamie are insiders
That's exactly what I am saying Doog!!!! Greg and Jamie are definitely (IMHO) privy to the transactions with VYST./ Come on Steve own's 42% of Rotman's and is President/CEO of VYST. Rotman's is a family business, operative word being family. Once the brothers take a step back, who do uyou think will be inheriting and running the company.....Greg and Jamie!!!!
That's exactly what I am saying. Rotman's is a family business both Greg and Jamie are intimately involved in day to day and IMHO privy to all the transactions with VYST.
Do you have any proof just the brothers signed.
Who do you think signed over 58% if Steve is holding 42%???? Come on really
Find what, Greg and Jamie signed over part of the 58% this has been discussed ad naseau. If they signed over their Rotman interest to do the merger/consolidation, I would imagine they looked st VYST's books and were privy to future developments, otherwise they would be investing blindly. Hence inside information, hence insiders. Period end of discussion
There is no confusion. Greg and Jamie signed over their share of Rotman's to VYST to effect the merger/consolidation. As such they are and were privy to information regarding VYST that no other investor had or was made public by VYST. Hence they have inside information, which makes them insiders. You are being so black and white when the fact remains it just isnt so!!!
You clearly see the board approved 1/19 and the transaction was effecuated till 7/5 so they reported correctly
The posting is rather clear, please read in it's entirety or google the information it's readily available.
What are the Listing Requirements for the Nasdaq?
FACEBOOK
TWITTER
LINKEDIN
BY MARY HALL Updated May 16, 2019
Major stock exchanges, like the Nasdaq, are exclusive clubs—their reputations rest on the companies they trade. As such, the Nasdaq won't allow just any company to be traded on its exchange. Only companies with a solid history and top-notch management behind them are considered.
The Nasdaq has four sets of listing requirements. Each company must meet at least one of the four requirement sets, as well as the main rules for all companies.
Listing Requirements for All Companies
Each company must have a minimum of 1,250,000 publicly traded shares upon listing, excluding those held by officers, directors or any beneficial owners of more than 10% of the company.
Also, the regular bid price at the time of listing must be $4.00, and there must be at least three market makers for the stock.
However, a company may qualify under a closing price alternative of $3.00 or $2.00 if the company meets varying requirements.
Each listing firm is also required to follow Nasdaq corporate governance rules 4350, 4351 and 4360.
Companies must also have at least 450 round lot (100 shares) shareholders, 2,200 total shareholders, or 550 total shareholders with 1.1 million average trading volume over the past 12 months.
The only thing we are missing to uplist is a $4.00 per share price. Which I believe once the deal is completed and financing for share buyback is in place we will be able to achieve.
Uplisting Power
Mar. 10, 2016 2:36 PM ET|5 comments | Includes: UNIR
Sergio Heiber
Sergio Heiber
Special situations, event-driven, newsletter provider, small-cap
(706 followers)
Summary
Stocks that uplist tend to experience an upside spike exceeding 25%.
The upside spike may not be sustained as the stock price becomes more reflective of the underlying fundamentals.
Not all OTC stocks rumored to be uplisting candidates are eligible for uplisting.
I was curious about the impact on stock price for an OTC stock that obtains a listing in one of the three major U.S. stock exchanges. I couldn't find any statistical information so I created my own analyses. This article is what I found about the OTC uplist process.
There are many companies that indicate that they will be applying for a listing but are far from eligible. This means that it is a perceived upgrade to be listed. Sure enough, there are stricter requirements for a listing, including SEC reporting and a listed company is generally considered a stronger company that an OTC stock. Additionally, many funds are prohibited by their own definition from buying OTC stocks. Obtaining a listing, therefore provides a greater pool of potential investors and greater liquidity as well as reducing the bid and ask spread.
OTC, or over the counter stocks, trade in a decentralized market not subject to reporting requirements as are listed stocks and offer less transparency. OTC stocks that are approved for a listing are called Jumpers.
NYSE listing requirements include a minimum price of $4 per share, 1.1 million shares outstanding with a market value of public shares in excess of $40 million, and a minimum of 400 round lot shareholders.
NASDAQ listing requirements include a minimum bid price of $4 per share, 1 million shares outstanding, at least 3 market makers, and a minimum of 300 round lot shareholders.
AMEX listing requirements must meet one of the following:
Have a pre-tax income in the most recent fiscal year or in two of the prior three fiscal years in excess of $750,000, a market value of the public float in excess of $3 million, a minimum stock price of $3, and total shareholders' equity in excess of $4 million.
Have a market value of the public float in excess of $15 million, a minimum stock price of $3, two years of operating history, and total shareholders' equity in excess of $4 million.
Have a total market capitalization in excess of $50 million, a market value of the public float in excess of $15 million, a minimum stock price of $2, and total shareholders' equity in excess of $4 million. The company must also meet a minimum number of round lot shareholders relative to the number of shares available in the public float.
For this study, I used stocks that were uplisted from OTC to one of the three major exchanges during the first three quarter of 2015. What I looked for was a spike in price prior to uplisting and ignored the overall trend if there was a spike on announcing application for listing. Then I looked at the spike in price on uplist and measured the spike in price over the subsequent short term. Finally, I looked at the current stock price, which is at least two quarters subsequent to the uplisting.
How an Uplisting Works
The potential uplisting of Biostar has created some misconceptions about how a stock makes its way to a major exchange.
Rick Pearson
Apr 14, 2010 12:30 PM EDT
Questions I've received about the timing of the potential uplisting of Biostar Pharmaceuticals (BSPM), one of my two favorite potential uplisting plays, makes it clear to me that many people hold a number of misconceptions about uplistings.
So let me post a few facts in response to specific questions people have had. Some of the questions have related to Biostar specifically and some to uplistings in general.
The complete rules for listing on the Nasdaq can be found here.
Fact No. 1. Uplisting isn't automatic. After a company meets all of the requirements for an uplisting, including financial requirements, corporate governance requirements and share price, it is still up to Nasdaq or Amex to give final approval. Sometimes, as in the case of SinoCoking ( SCOK), this happens almost immediately. Other times, as in the case of Subaye ( SBAY), it can take a number of weeks. The conclusions are that timing on uplistings is uncertain, timing depends entirely on Nasdaq approval, and it pays to be patient. Because I missed out on the massive Sinocoking run and a few others, I typically try to get in early and then be patient rather than waiting until it is too late.
Fact No. 2. The required share price to uplist to Nasdaq is $4. The price is determined by the bid price, not the closing price, of the stock. In April 2009, Nasdaq lowered its share price threshold to $4 from $5. This was presumably due to the impact that the financial crisis had on share prices, but could also be seen as a move to take some business from the Amex exchange. Both the Amex and the Nasdaq charge substantial listing fees to companies for listing on their exchanges and both are eager to maximize revenue. Amex has a lower required share price of $2 to $3 for an uplisting.
The requirements for an Amex listing can be found here.
The reason that the bid is used instead of the closing price is that the bid more accurately reflects demand for the stock and is hard to manipulate, unlike the closing price, which can be influenced by a single trade. However, if the closing share price of a company is right at $4, then chances are that its closing bid was below $4. So looking at share-price histories alone can be misleading.
Fact No. 3. It doesn't take 90 trading days with a bid above $4 to uplist to Nasdaq.
The 90-day misconception comes from the fact that some companies that are not yet profitable and that lack an adequate operating history can still list on Nasdaq, but only if their bid price is above $4 for 90 consecutive trading days and if they meet other criteria.
This doesn't apply to profitable companies such as Biostar. Again, a good example of a much faster uplist is Sinocoking, which took only seven consecutive trading days after the time it traded at $3.50 on Feb 9 to the time it announced its uplisting on Feb. 19. However, as always, Nasdaq reserves the right to take longer than this based on its own criteria.
A separate misconception is 30 days. The 30-day misconception comes from people getting confused with the delisting requirements of Nasdaq. The 30-day trigger is the delisting trigger, not the uplisting trigger. When a company trades below $1, such as Sirius XM ( SIRI - Get Report) recently did, it gets a letter from Nasdaq that says something like this:
"On September 15, 2009, Staff notified the Company that the bid price of its common stock had closed at less than $1.00 per share over the previous 30 consecutive business days, and, as a result, did not comply with Listing Rule 5450(a)(1) (the "Rule"). In accordance with Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until March 15, 2010, to regain compliance with the Rule."
(Note: Given that SIRI has a market cap of nearly $4 billion, it is unlikely that it will be delisted and more likely that Sirius will do a reverse split and remain listed).
Fact No. 4 . Reverse splits are a sign of good things for companies on the way up, but a sign of bad things for companies on the way down.
In order to meet the minimum share price requirements for Nasdaq, many companies will conduct a reverse split. This is perfectly acceptable to the exchange, and the post-split share price will be evaluated accordingly.
Using a reverse split to raise the share price and obtain an uplisting is a very positive sign for a company and is much different than companies that use a reverse split to prevent being delisted. Once again, the confusion relates to delisting as opposed to uplisting. Many people who don't focus on uplistings only encounter reverse splits in the context of companies that are trying to stave off a delisting, so in many people's eyes a reverse split is a sign of a troubled company.
For the relative few of us focused on uplistings, a reverse split is typically the first catalyst that attracts attention to the potential uplisting and is considered a very good event.
As for the timing on the uplisting for Biostar, that is solely up to Nasdaq. However, according to the company's chief financial officer, the company already meets all of the corporate governance requirements and has already applied to Nasdaq for an uplisting.
On Tuesday, Biostar's last aftermarket price was $4.35 and the closing bid was $4.30.
At the time of publication, Pearson was long Biostar.
From “Pink Sheets” To NASDAQ. A Case Study in OTC-To-NASDAQ Up-listing.
James P. Moore
James P. Moore in Data Driven Investor
Follow
Sep 30, 2018 · 4 min read
Can you hear me now?
Recently, I wrote a small piece on a one of the medical companies I did some analysis for (Investment S. EDI), and one of them stood out. A small company called Innerscope Hearing Technologies (OTCQB:INND) has been making its rounds in the media as it has put large hearing aid companies on notice. While I do believe it is a great little company, I failed to research it further. To be frank, I was a bit surprised by what I found. I believe I have uncovered a “LIVE” case study in how a small company (well, appearing to be small) is positioned perfectly to up-list to the NASDAQ.
In an attempt to make this report less than 100 pages, I will simply provide a case study comparative analysis on a similar company in the same sector, producing the same product line, but listed on the NASDAQ. You maybe be quite surprised how similar they are, and might think at first glace, they should be same share price. Are you ready for this?
Let’s look at IntriCon Corporation (NASDQ:IIN). Share Price: $56.20(-4.26% on previous close).
Let’s focus for now on the share price. NASDAQ listed at $56.20. Now, let’s compare this company that is trading at $56.20 to a similar company, and then at the end, compare the share price, and see if it makes sense.
We will be comparing it to OTCQB:INND Innerscope Hearing Technologies.
Technology:
InnerScope is using the latest in advancements in Hearing Technology by exclusively using Receiver in the Canal (RIC) Technology and Form Factor. While IntriCon uses older Behind the Ear (BTE) Technology.
So what? What are the Advantages of an RIC over a BTE
The receiver and microphone components are positioned much further apart compared to a BTE, meaning there is ordinarily less feedback than the equivalent BTE. Generally the RIC is smaller than the corresponding battery size BTE, due to part of the component sitting in the ear canal rather than the outer casing.
Two standard types of hearing aid (behind-the-ear and in-the-ear) are designed to keep the device component all in one case (behind the ear and in the ear respectively). RIC devices use a different strategy, separating the device’s components into two sections. A case behind the ear holds the aid’s amplifier and microphone, while a small bud that contains the receiver is used inside the ear canal. The receiver is connected to the case by a thin tube.
Found on INND Twitter Feed
There are several advantages associated with separating the receiver from the microphone and amplifier. RIC hearing aids are less likely to inundate listeners with feedback, and occlusion is generally less of a problem. These devices also tend to procedure a more natural sound, allowing listeners to enjoy a more comfortable experience. High-pitched tones are amplified particularly well, making receiver in canal hearing aids very suitable for individuals suffering from mild to moderate hearing loss.
The split configuration of the RIC has a few other advantages. Separating the two components allows the device to remain very small, making it unobtrusive and easy to hide. Its small size also allows it to fit very comfortably in and on the ear.
Corporate Owned Stores:
InnerScope has acquired audiological and Hearing Aid retail clinics, and has a plan to have 6 locations fully operational by December 2018. InnerScope will be opening additional locations in 1st half of 2019. Each clinic has a revenue potential between 500k to $2M per year. Currently IntriCon does not own any clinics.
Let’s repeat that. The company that is trading at $56.20, does not own any clinics.
So, comparing INND to IIN, how much higher do you think the share price of INND is compared to IIN? It’s not even close. Remember, IIN is trading at $56.20…. INND is currently trading in the pink sheets at $0.065.
Why? The company decided to start in the Over-The-Counter markets to raise money their first, then move on the NASDAQ. I have covered corporate moves like this in the past, and this is a perfect case study of a small company doing a good job keeping it appearing to be small, which strategically aligning their assets and acquisitions to move quickly to NASDAQ. I believe in 2019 we will see INND hit some where around $1.00 in the first quarter, then moving on to higher share prices as it uplists.
Please keep in mind, like all my other articles and analysis reports, this is my opinion and it does not resemble the views of my department nor company. I would urge all to treat this is a entertainment piece, as everyone should do their own analysis prior to investing.
Picked up another 50K between yesterday and today
Or who's buying
5 miliion in a sea of 1 billion
Get real this type of compensation is done every day all day for all types of corporations. It indicates the fact that these individuals play an important role and they want them to stay around!!!